Miller Wealth Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$229 Hold
38
﹤0.01% 108
2025
Q4
$273 Hold
38
﹤0.01% 124
2025
Q3
$406 Hold
38
﹤0.01% 102
2025
Q2
$368 Hold
38
﹤0.01% 94
2025
Q1
$565 Buy
38
+1
+3% +$15 ﹤0.01% 93
2024
Q4
$558 Hold
37
﹤0.01% 87
2024
Q3
$651 Hold
37
﹤0.01% 80
2024
Q2
$757 Buy
37
+1
+3% +$20 ﹤0.01% 76
2024
Q1
$681 Hold
36
﹤0.01% 77
2023
Q4
$516 Buy
36
+1
+3% +$14 ﹤0.01% 79
2023
Q3
$612 Hold
35
﹤0.01% 71
2023
Q2
$726 Sell
35
-181
-84% -$3.93K ﹤0.01% 71
2023
Q1
$14K Buy
216
+158
+272% +$4.24K 0.07% 35
2022
Q4
$2K Buy
58
+24
+71% +$614 ﹤0.01% 71
2022
Q3
$1K Hold
34
﹤0.01% 88
2022
Q2
$1K Hold
34
﹤0.01% 86
2022
Q1
$1K Buy
34
+1
+3% +$34 ﹤0.01% 88
2021
Q4
$1K Buy
+33
New +$1.07K ﹤0.01% 93

Other funds holding OGN

Miller Wealth Advisors's OGN Position: Q1 2026 in Review

Miller Wealth Advisors held its Organon & Co (OGN) position steady in Q1 2026 at 38 shares worth $229. The position accounts for ﹤0.01% of the portfolio, ranked #108.

Miller Wealth Advisors first reported a position in OGN in Q4 2021 and has held it in 18 quarters since. The position peaked at $14K in Q1 2023. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Miller Wealth Advisors held 38 shares of Organon & Co worth $229 as of Q1 2026.
  • Miller Wealth Advisors left its Organon & Co share count unchanged in Q1 2026.
  • Organon & Co made up ﹤0.01% of Miller Wealth Advisors's portfolio in Q1 2026, its #108 holding.
  • Miller Wealth Advisors first reported a position in Organon & Co in Q4 2021 and has held it in 18 quarters since.
  • Miller Wealth Advisors's Organon & Co position peaked at $14K in Q1 2023.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Miller Wealth Advisors's 13F filing for Q1 2026, filed 1 May 2026.